Skip to content

Bioalmanac

Bromantane

Ladasten · ADK-709 · N-(2-adamantyl)-N-(para-bromophenyl)amine

Approved for another indication

Status reviewed 18 Aug 2026

Prohibited in sport

A Russian anti-asthenic drug, and a documented doping agent. It produced a positive test at the 1996 Olympics and is prohibited by WADA.

Storage

Freeze-dried powder
Tablets or powder at room temperature, dry and out of light.
After mixing
Not applicable — this is taken orally.

Dose ranges reported in sources

Descriptions of what sources report, not recommendations.

GoalRangeFrequencySource
Registered Russian dosing50000–100000 mcg50 to 100 mg daily, in courses of 2 to 4 weeksPublished review

When to stop

  • Sleep disturbance that does not settle.
  • Agitation, anxiety or mood change.
  • Persistent headache.
  • Any allergic response: rash, hives, facial swelling or difficulty breathing. Seek urgent care.

Registered in Russia as Ladasten for asthenic conditions. Not approved in the United States or the European Union, and prohibited in sport by the World Anti-Doping Agency following positive tests at the 1996 Olympics.

Arithmetic on values you enter. Not medical advice. Not reviewed by a clinician. · bioalmanac.com/peptides/bromantane

Use your browser’s print dialog and choose “Save as PDF”. This block is hidden when printed.